نتایج جستجو برای: mafosfamide

تعداد نتایج: 66  

Journal: :Pharmacological reports : PR 2013
Jolanta D Żołnierczyk Arleta Borowiak Jerzy Z Błoński Barbara Cebula-Obrzut Małgorzata Rogalińska Aleksandra Kotkowska Ewa Wawrzyniak Piotr Smolewski Tadeusz Robak Zofia M Kiliańska

BACKGROUND The heterogeneity of chronic lymphocytic leukemia (CLL) is thought to be due to differences in the expression of factors that regulate apoptosis and cell cycle, giving rise to diverse apoptotic disturbances and tumor properties. Therefore, the primary goal in CLL treatment is to overcome resistance to apoptosis and efficiently trigger this process in leukemic cells. METHODS Mononuc...

Journal: :Blood 1990
R Pieters A H Loonen D R Huismans G J Broekema M W Dirven M W Heyenbrok K Hählen A J Veerman

The knowledge about drug resistance in childhood leukemias and acute lymphoblastic leukemia (ALL) in general is limited. This is because of the lack of a suitable in vitro drug sensitivity assay, which is in part due to low in vitro ALL cell survival. We recently adapted the highly efficient 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) assay to test cells from ALL patient...

Journal: :Blood 1994
J P Laporte L Douay M Lopez M Labopin J P Jouet S Lesage J Stachowiak L Fouillard F Isnard M P Noel-Walter

A total of 125 acute leukemia adult patients were autografted with bone marrow (BM) purged by mafosfamide (ASTA Z) during the period of January 1983 to January 1993. The median follow-up period was 64 months (range, 3 to 126). There were 84 acute myeloblastic leukemias (AMLs) and 41 acute lymphoblastic leukemias (ALLs). At time of autologous BM transplantation (ABMT); 64 AMLs were in first comp...

Journal: :Blood 1990
N C Gorin P Aegerter B Auvert G Meloni A H Goldstone A Burnett A Carella M Korbling P Herve D Maraninchi

We analyzed data from 263 patients with acute myelocytic leukemia (AML) autografted in first remission (CR) during the period from January, 1982 to January, 1987 at one of 34 centers in the European Bone Marrow Transplant Group. The median age of patients was 30 years (range, 1 to 65). The median interval between achieving CR and autografting was 5 months (range, 1 to 23). Of the 263 patients, ...

2017
Małgorzata Rogalińska Paweł Góralski Jerzy Z. Błoński Paweł Robak Jan Barciszewski Aneta Koceva-Chyła Henryk Piekarski Tadeusz Robak Zofia M. Kilianska

There is individual variation in the course of disease development and response to therapy of patients with chronic lymphocytic leukemia (CLL). Novel treatment options for CLL include a new generation of purine analogs, antibodies and inhibitors of specific cell signaling pathways, which typically induce apoptosis or necrosis. A prospective analysis of patient blood samples revealed that a comb...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید